Aridis Pharmaceuticals, Inc.
ARDS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,371 | -$42,193 | -$22,333 | -$29,681 |
| Dep. & Amort. | $487 | $435 | $337 | $338 |
| Deferred Tax | $0 | -$722 | $0 | $0 |
| Stock-Based Comp. | $1,479 | $2,251 | $2,128 | $2,010 |
| Change in WC | -$1,299 | $10,517 | -$617 | $18,223 |
| Other Non-Cash | $577 | $6,776 | $9 | $951 |
| Operating Cash Flow | -$29,127 | -$22,936 | -$20,476 | -$8,159 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$82 | -$530 | -$367 | -$174 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$82 | -$530 | -$367 | -$174 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $3,200 | $5,000 | $715 | $0 |
| Stock Issued | $12,609 | $29,715 | $7,949 | $4,958 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$4,127 | $0 | $0 |
| Other Fin. Act. | -$1,027 | $4,132 | $14 | $35 |
| Financing Cash Flow | $14,782 | $34,720 | $8,678 | $4,993 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14,427 | $11,254 | -$12,165 | -$3,340 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $19,986 | $8,732 | $20,897 | $24,237 |
| End Cash | $5,559 | $19,986 | $8,732 | $20,897 |
| Free Cash Flow | -$29,209 | -$23,466 | -$20,843 | -$8,333 |